The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2022
Filed:
Apr. 26, 2018
Applicant:
Receptos Llc, New York, NY (US);
Inventors:
Junko Tamiya, Carlsbad, CA (US);
Philip Turnbull, San Diego, CA (US);
Brahmachary Enugurthi, San Diego, CA (US);
Liming Huang, San Diego, CA (US);
Adam R. Yeager, La Mesa, CA (US);
Thomas Fowler, Leicestershire, GB;
Greg P. Iacobini, Nottinghamshire, GB;
Matthew Richard Crittall, Nottinghamshire, GB;
Assignee:
Receptos LLC, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/12 (2006.01); C07D 239/26 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 413/12 (2013.01); C07D 239/26 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 417/12 (2013.01);
Abstract
Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as products containing such compounds, and methods of their use and synthesis. Such compounds have the structure of Formula (I) below: (I) or pharmaceutically acceptable salts thereof, wherein A, J, W, Y, Z, R, R, Rand Rare as defined herein.